Abstract

To explore a possible recessive selective marker for future DNA-free genome editing by direct delivery of a CRISPR/Cas9-single guide RNA (sgRNA) ribonucleoprotein complex, we knocked out homologs of the Arabidopsis Multi-Antibiotic Resistance 1 (MAR1)/RTS3 gene, mutations of which confer aminoglycoside resistance, in tobacco plants by an efficient Agrobacterium-mediated gene transfer. A Cas9 gene was introduced into Nicotiana tabacum and Nicotiana sylvestris together with an sgRNA gene for one of three different target sequences designed to perfectly match sequences in both S- and T-genome copies of N. tabacum MAR1 homologs (NtMAR1hs). All three sgRNAs directed the introduction of InDels into NtMAR1hs, as demonstrated by CAPS and amplicon sequencing analyses, albeit with varying efficiency. Leaves of regenerated transformant shoots were evaluated for aminoglycoside resistance on shoot-induction media containing different aminoglycoside antibiotics. All transformants tested were as sensitive to those antibiotics as non-transformed control plants, regardless of the mutation rates in NtMAR1hs. The NtMAR1hs–knockout seedlings of the T1 generation showed limited aminoglycoside resistance but failed to form shoots when cultured on shoot-induction media containing kanamycin. The results suggest that, like Arabidopsis MAR1, NtMAR1hs have a role in plants’ sensitivity to aminoglycoside antibiotics, and that tobacco has some additional functional homologs.

Highlights

  • IntroductionIn addition to conventional crossbreeding, gene manipulation technologies have been applied to improve crop plants

  • Published: 11 February 2022In addition to conventional crossbreeding, gene manipulation technologies have been applied to improve crop plants

  • Because we aimed to evaluate whether the knockout of tobacco Multi-Antibiotic Resistance 1 (MAR1) homologs could serve as a selection marker in future DNAfree genome editing, we tested plants with high and low mutation rates for their shoot regeneration capacity on media containing different aminoglycoside antibiotics

Read more

Summary

Introduction

In addition to conventional crossbreeding, gene manipulation technologies have been applied to improve crop plants. Different transgenic crops have been bred since the 1980s, but only a few are successful in commercial production. Many countries have legal regulations to constrain the use of genetically modified (GM) crops. Some people are concerned or uncertain about using GM crops as foods [1,2], which could be a limiting factor for the popularization of GM crops. Transgenic technology introduces foreign genes into the crop genome to confer desired traits. Genome editing technology can modify existing crop genes, as can conventional mutagenesis, but with more precision [3,4]. Genome editing has the potential to become a significant crop breeding technology, with higher levels of public acceptance than transgenic technology

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call